公司資料
Leap Therapeutics 股價、新聞與催化劑
- 股票代碼:
- LPTX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for LPTX.
公司概覽
業務概覽
Leap Therapeutics is an oncology company focused on targeted therapies and tumor biology. Its platform is aimed at differentiated cancer mechanisms, especially in solid tumors.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Leap sits in specialty oncology biotechnology.
商業模式特徵
The business depends on clinical data, target differentiation, and the ability to build a durable cancer story.
生技產業定位
Leap is a small-cap oncology catalyst name whose stock reacts to early readouts and program progress.
未來催化劑
- Leap’s catalysts are sirexatamab / oncology pipeline updates and any strategic step that clarifies how much value the company still has. The market wants a cleaner path.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。